Navigation Links
Worm Therapy Shows Promise for Ulcerative Colitis
Date:12/1/2010

By Julia VanTine
HealthDay Reporter

WEDNESDAY, Dec. 1 (HealthDay News) -- The case of a man who swallowed parasite eggs to treat his ulcerative colitis -- and actually got better -- sheds light on how "worm therapy" might help heal the gut, a new study suggests.

"Our findings in this case report suggest that infection with the eggs of the T. trichiura roundworm can alleviate the symptoms of ulcerative colitis," said study leader P'ng Loke, an assistant professor in the department of medical parasitology at NYU Langone Medical Center. A human parasite, Trichuris trichiura infects the large intestine.

The findings could also lead to new ways to treat the debilitating disease, a form of inflammatory bowel disease (IBD) currently treated with drugs that don't always work and can cause serious side effects, said Loke.

The study findings are published in the Dec. 1 issue of Science Translational Medicine.

Loke and his team followed a 35-year-old man with severe colitis who tried worm (or "helminthic") therapy to avoid surgical removal of his entire colon. He researched the therapy, flew to a doctor in Thailand who had agreed to give him the eggs, and swallowed 1,500 of them.

The man contacted Loke after his self-treatment and "was essentially symptom-free," Loke said. Intrigued, he and his colleagues decided to follow the man's condition.

The study analyzed slides and samples of the man's blood and colon tissue from 2003, before he swallowed the eggs, to 2009, a few years after ingestion. During this period, he was virtually symptom-free for almost three years. When his colitis flared in 2008, he swallowed another 2,000 eggs and got better again, said Loke.

Tissue taken during active colitis showed a large number of CD4+ T-cells, which are immune cells that produce the inflammatory protein interleukin-17, the team found. However, tissue taken after worm therapy, when his colitis was in remission, contained lots of T-cells that make interleukin-22 (IL-22), a protein that promotes wound healing.

Further, after worm therapy, the man's colon produced significantly more mucus, said Loke, who noted that a lack of mucus in the colon is linked with severe symptoms. "We think the worms increase or restore mucus production in the colon," he said. "Basically, the gut is trying to expel the worms. This increase in mucus may play a role in relieving the symptoms."

"This is not the usual clinical trial, but you take your opportunities for unique observation where you can," said Dr. Gerald W. Dryden Jr., director of the clinical research division of gastroenterology, hepatology and nutrition at the University of Louisville, in Kentucky.

Before this study, IL-22 had not been associated with beneficial effect in IBD, said Dryden. "While it doesn't determine cause-and-effect, the study does seem to demonstrate an important, previously unknown association between IL-22 and response to helminthic therapy," he said.

Causing abdominal pain, diarrhea and other symptoms, colitis affects about 700,000 Americans, according to the Crohn's and Colitis Foundation of America. Scientists don't know what causes the disease, but theorize that immune-system dysfunction plays a role.

Colitis is common in developed countries such as America -- where parasitic worm infections are rare -- and in Asia, Africa and Latin America, where virtually the entire population is infected, the study noted. Clinical trials with the pig whipworm Trichuris suis have improved the symptoms of both ulcerative colitis and Crohn's disease, and animal studies suggest that various parasitic worms can suppress inflammation, the study noted.

The study also suggests new, worm-based treatments for both ulcerative colitis and IBD. Research might identify molecules derived from worms that suppress inflammation, or pathways activated by worms that can be targeted by more conventional approaches, Loke said.

Right now, however, worm therapy is still not well-understood and could potentially backfire, the study warned. "The problem is that these worms themselves can cause harm and damage the gut," said Loke. "The individual in this study is lucky to have responded so well, but for other people the worm infection may exacerbate bowel inflammation." Studies that use the pig worm, which should pose less risk to humans, are under way, he added.

More information

For more about ulcerative colitis, head to the U.S. National Digestive Diseases Information Clearinghouse.

SOURCES: P'ng Loke, assistant professor, department of medical parasitology, NYU Langone Medical Center, New York City; Gerald W. Dryden Jr., director, clinical research division, gastroenterology, hepatology and nutrition, University of Louisville, Kentucky; Dec. 1, 2010, Science Translational Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sixth global conference on stem cell therapy to be held Jan. 20-21, 2011, in New York City
2. Breast Cancer Rates Lower With Less Hormone Therapy: Study
3. Drop in breast cancer rates directly tied to reduced hormone therapy
4. Gene therapy prevents memory problems in mice with Alzheimers disease
5. Gene therapy for metastatic melanoma in mice produces complete remission
6. Neuralstem files FDA application for first drug therapy
7. Combination therapy improves survival time for patients with advanced liver cancer
8. Gene Therapy Shows Potential Against Heart Failure
9. Hearing loss common following radiation therapy for head and neck cancer
10. Targeted therapy reactivates guardian of the genome in resistant cancer
11. GUMC: fMRI predicts outcome to talk therapy in children with an anxiety disorder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Worm Therapy Shows Promise for Ulcerative Colitis
(Date:12/5/2016)... ... December 05, 2016 , ... ... lines. The goal of Castlewood Treatment Centers has always been to promote the ... as many people as possible. In that spirit, Castlewood has announced two new ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... Clinical Officer for the Florida Hospital West Florida Region. McGuinness brings experience in ... leading and engaging staff, physicians and leaders. , In her new role, that ...
(Date:12/5/2016)... ... ... has joined the Retina Group of New York (RGONY) specializing in uveitis and ... and has been providing tertiary medical and surgical retinal care on Long Island for over ... peers. Growing up in a family of doctors, Dr. Shah emulated the role of ...
(Date:12/5/2016)... ... December 05, 2016 , ... Z-Medica, LLC, a leading developer ... The American College of Surgeons (ACS) to provide basic bleeding control instructor training ... Basic” course is a pilot program that fulfills the intent of the White ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ ... Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - ... reach USD 779.8 Million by 2021 from USD 414.6 Million in ... of 2016 to 2021. Continue Reading ... ...
(Date:12/5/2016)... , December 5, 2016 According to a new ... and by Application - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", ... expected to reach $5,255 million by 2022, growing at a CAGR of 6.4% ... more than four-fifths share. Continue Reading ... ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 ... Allied Market Research, titled, "Global Cancer Biomarkers Market - Global ... cancer biomarkers market is projected to reach $15,737 million by ... 13.3% from 2016 to 2022. Omic technologies segment accounted for ... is expected to maintain its dominance during the forecast period. ...
Breaking Medicine Technology: